claim: therapeutic anticoagulation is associated with elevated mortality in mechanically ventilated covid-19 patients
evidence_1: a multivariate cox proportional hazard regression model with ps weights to adjust for baseline differences found a 79% reduction in death in patients who were therapeutically anticoagulated hr 0.209, [95% cl (0.10, 0.46), p < 0.001].", "results propensity score (ps) weighted kaplan-meier plot demonstrated a survival advantage (57% vs. 25%) at 35 days from admission to the icu in patients who received therapeutic anticoagulation for a minimum of 5 days compared to those who received prophylactic anticoagulation during their hospital course.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "conclusions therapeutic anticoagulation is associated with a survival advantage among patients with covid-19 who require mechanical ventilation in the icu.")